Edwin C. Frias

1.2k total citations · 1 hit paper
11 papers, 397 citations indexed

About

Edwin C. Frias is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Edwin C. Frias has authored 11 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Edwin C. Frias's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and Hepatitis C virus research (2 papers). Edwin C. Frias is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and Hepatitis C virus research (2 papers). Edwin C. Frias collaborates with scholars based in United States, Germany and Austria. Edwin C. Frias's co-authors include John C. Prostko, Susan Cheng, Min Wu, Nancy Sun, James L. Stewart, Kimia Sobhani, Joseph E. Ebinger, Jennifer E. Van Eyk, Justyna Fert‐Bober and Jonathan Braun and has published in prestigious journals such as Nature Medicine, The Journal of Infectious Diseases and Acta Paediatrica.

In The Last Decade

Edwin C. Frias

9 papers receiving 394 citations

Hit Papers

Antibody responses to the BNT162b2 mRNA vaccine in indivi... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwin C. Frias United States 5 367 64 62 57 52 11 397
Regina Maruste Estonia 3 352 1.0× 71 1.1× 93 1.5× 54 0.9× 53 1.0× 4 390
John C. Prostko United States 8 481 1.3× 67 1.0× 65 1.0× 61 1.1× 56 1.1× 20 540
Natthinee Sudhinaraset Thailand 12 312 0.9× 56 0.9× 98 1.6× 35 0.6× 51 1.0× 29 370
Sandra Hauka Germany 5 406 1.1× 57 0.9× 66 1.1× 39 0.7× 62 1.2× 7 473
Savannah K. McBride United States 8 358 1.0× 39 0.6× 62 1.0× 58 1.0× 49 0.9× 9 383
Suvichada Assawakosri Thailand 9 286 0.8× 59 0.9× 91 1.5× 45 0.8× 30 0.6× 22 299
Donchida Srimuan Thailand 11 296 0.8× 57 0.9× 108 1.7× 50 0.9× 32 0.6× 27 362
Wai Hung Chan China 7 328 0.9× 35 0.5× 35 0.6× 27 0.5× 37 0.7× 11 373
Kin Ho Chan Hong Kong 5 535 1.5× 78 1.2× 34 0.5× 39 0.7× 39 0.8× 5 588
Adam Brosz United States 4 363 1.0× 78 1.2× 79 1.3× 54 0.9× 30 0.6× 4 399

Countries citing papers authored by Edwin C. Frias

Since Specialization
Citations

This map shows the geographic impact of Edwin C. Frias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin C. Frias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin C. Frias more than expected).

Fields of papers citing papers by Edwin C. Frias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin C. Frias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin C. Frias. The network helps show where Edwin C. Frias may publish in the future.

Co-authorship network of co-authors of Edwin C. Frias

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin C. Frias. A scholar is included among the top collaborators of Edwin C. Frias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin C. Frias. Edwin C. Frias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Farnsworth, Christopher W, John C. Prostko, Gerard J. Davis, et al.. (2025). Systemic inflammation is associated with worse outcomes from SARS-CoV-2 infection but not neutralizing antibody. Microbiology Spectrum. 13(4). e0245924–e0245924. 1 indexed citations
2.
Ebinger, Joseph E., Nancy Sun, Sandy Joung, et al.. (2024). Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior Infection or Vaccination. The Journal of Infectious Diseases. 230(3). e584–e590.
3.
Prostko, John C., Richard E. Rothman, Yu‐Hsiang Hsieh, et al.. (2024). Performance evaluation of the Abbott Alinity Hepatitis C antigen next assay in a US urban emergency department population. Journal of Clinical Virology. 175. 105743–105743.
4.
Jordan, Stanley C., Sandy Joung, Christine Chang, et al.. (2023). Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS‐CoV‐2 infections in solid organ transplant recipients. Transplant Infectious Disease. 26(1). e14182–e14182. 4 indexed citations
5.
Chensue, Stephen W., Paul S. Kim, Derek E. Dimcheff, et al.. (2022). SARS-CoV-2 Anti-Spike IgG Antibody and ACE2 Receptor Binding Inhibition Levels among Breakthrough Stage Veteran Patients. Microbiology Spectrum. 10(6). e0274722–e0274722. 2 indexed citations
6.
Joung, Sandy, Joseph E. Ebinger, Nancy Sun, et al.. (2022). Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity. JAMA Network Open. 5(8). e2227241–e2227241. 27 indexed citations
7.
Daghfal, David, et al.. (2022). Specificity and Confirmation of SARS-CoV-2 Serological Test Methods in Emergency Department Populations across the United States. The Journal of Applied Laboratory Medicine. 7(6). 1424–1429. 2 indexed citations
8.
Ebinger, Joseph E., Justyna Fert‐Bober, Min Wu, et al.. (2021). Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nature Medicine. 27(6). 981–984. 343 indexed citations breakdown →
9.
Marohnic, Christopher C., Larry G. Birkenmeyer, Edwin C. Frias, et al.. (2018). Engineering of the hepatitis C virus helicase for enhanced seroreactivity. Journal of Virological Methods. 264. 11–17. 1 indexed citations
10.
Prostko, John C., Edwin C. Frias, Dominick Pucci, et al.. (2009). Evaluation of the Abbott ARCHITECT Toxo IgM assay. Diagnostic Microbiology and Infectious Disease. 64(3). 275–282. 11 indexed citations
11.
Rodrı́guez, Carmen, et al.. (1989). Comparative Functional Study of Colostral Macrophages from Mothers Delivering Preterm and at Term. Acta Paediatrica. 78(3). 337–341. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026